Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 50 articles: HTML format Text format

Single Articles

September 2018
1. VAN LIDTH DE JEUDE JF, Spaan CN, Meijer BJ, Smit WL, et al
   Heterozygosity of chaperone Grp78 reduces intestinal stem cell regeneration potential and protects against adenoma formation.
   Cancer Res. 2018 Sep 19. pii: 0008-5472.CAN-17-3600.
   PubMed     Text format     Abstract available
   
   
   
2. CHEN C, Okita Y, Watanabe Y, Abe F, et al
   Glycoprotein nmb is exposed on the surface of dormant breast cancer cells and induces stem cell-like properties.
   Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-0599.
   PubMed     Text format     Abstract available
   
   
   August 2018
3. KOIFMAN G, Shetzer Y, Eizenberger S, Solomon H, et al
   A mutant p53-dependent embryonic stem cell gene signature is associated with augmented tumorigenesis of stem cells.
   Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0805.
   PubMed     Text format     Abstract available
   
   
   
4. BAYLEY R, Blakemore D, Cancian L, Dumon S, et al
   MYBL2 supports DNA double strand break repair in haematopoietic stem cells.
   Cancer Res. 2018 Aug 6. pii: 0008-5472.CAN-18-0273.
   PubMed     Text format     Abstract available
   
   
   June 2018
5. QAZI MA, Vora P, Venugopal C, Adams J, et al
   Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
   Cancer Res. 2018 Jun 26. pii: 0008-5472.CAN-18-0267.
   PubMed     Text format     Abstract available
   
   
   
6. LU H, Tran L, Park Y, Chen I, et al
   Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF-1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
   Cancer Res. 2018 Jun 7. pii: 0008-5472.CAN-18-0270.
   PubMed     Text format     Abstract available
   
   
   May 2018
7. MATSUNAGA N, Ogino T, Hara Y, Tanaka T, et al
   Optimized dosing schedule based on circadian dynamics of mouse breast cancer stem cells improves the anti-tumor effects of aldehyde dehydrogenase.
   Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4034.
   PubMed     Text format     Abstract available
   
   
   
8. HU T, Chong Y, Lu S, Wang R, et al
   MicroRNA 339 promotes development of Stem Cell Leukemia/Lymphoma syndrome via downregulation of the BCL2L11 and BAX pro-apoptotic genes.
   Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4049.
   PubMed     Text format     Abstract available
   
   
   April 2018
9. RESAR L, Chia L, Xian L
   Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
   Cancer Res. 2018 Apr 4. pii: 0008-5472.CAN-17-3045.
   PubMed     Text format     Abstract available
   
   
   March 2018
10. REN D, Zhu X, Kong R, Zhao Z, et al
    Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
    Cancer Res. 2018 Mar 22. pii: 0008-5472.CAN-17-2994.
    PubMed     Text format     Abstract available
    
    
    
11. HALL AW, Battenhouse AM, Shivram H, Morris AR, et al
    Bivalent chromatin domains in glioblastoma reveal a subtype-specific signature of glioma stem cells.
    Cancer Res. 2018 Mar 16. pii: 0008-5472.CAN-17-1724.
    PubMed     Text format     Abstract available
    
    
    
12. CONDELLO S, Sima LE, Ivan C, Cardenas H, et al
    Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche.
    Cancer Res. 2018 Mar 6. pii: 0008-5472.CAN-17-2319.
    PubMed     Text format     Abstract available
    
    
    February 2018
13. JUNG Y, Cackowski FC, Yumoto K, Decker A, et al
    CXCL12gamma Promotes Development of Metastatic Castration Resistant Prostate Cancer by Induction of Cancer Stem Cell and Neuroendocrine Phenotypes.
    Cancer Res. 2018 Feb 5. pii: 0008-5472.CAN-17-2332.
    PubMed     Text format     Abstract available
    
    
    January 2018
14. JIAO X, Velasco-Velazquez MA, Wang M, Li Z, et al
    CCR5 governs DNA damage and breast cancer stem cell expansion.
    Cancer Res. 2018 Jan 22. pii: 0008-5472.CAN-17-0915.
    PubMed     Text format     Abstract available
    
    
    
15. LIU C, Nie D, Li J, Du X, et al
    Antitumor effects of blocking protein neddylation in T315I-BCR-ABL leukemia cells and leukemia stem cells.
    Cancer Res. 2018 Jan 10. pii: 0008-5472.CAN-17-1733.
    PubMed     Text format     Abstract available
    
    
    
16. TIMANER M, Letko-Khait N, Kotsofruk R, Benguigui M, et al
    Therapy-educated mesenchymal stem cells enrich for tumor initiating cells.
    Cancer Res. 2018 Jan 4. pii: 0008-5472.CAN-17-1547.
    PubMed     Text format     Abstract available
    
    
    December 2017
17. BROCK A, Huang S
    Precision Oncology: Between Vaguely Right and Precisely Wrong.
    Cancer Res. 2017;77:6473-6479.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. HUANG WY, Lai SF, Chiu HY, Chang M, et al
    Mobilizing Transit-Amplifying Cell-Derived Ectopic Progenitors Prevents Hair Loss from Chemotherapy or Radiation Therapy.
    Cancer Res. 2017;77:6083-6096.
    PubMed     Text format     Abstract available
    
    
    
19. CHIBA Y, Mizoguchi I, Furusawa J, Hasegawa H, et al
    Interleukin-27 Exerts Its Antitumor Effects by Promoting Differentiation of Hematopoietic Stem Cells to M1 Macrophages.
    Cancer Res. 2017 Nov 1. pii: canres.0960.2017.
    PubMed     Text format     Abstract available
    
    
    
20. SERVIDEI T, Meco D, Muto V, Bruselles A, et al
    Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.
    Cancer Res. 2017;77:5860-5872.
    PubMed     Text format     Abstract available
    
    
    
21. ISHIGAKI H, Maeda T, Inoue H, Akagi T, et al
    Transplantation of iPS-Derived Tumor Cells with a Homozygous MHC Haplotype Induces GRP94 Antibody Production in MHC-Matched Macaques.
    Cancer Res. 2017;77:6001-6010.
    PubMed     Text format     Abstract available
    
    
    October 2017
22. HOUSE CD, Jordan E, Hernandez L, Ozaki M, et al
    NF-kB promotes ovarian tumorigenesis via classical pathways supporting proliferative cancer cells and alternative pathways supporting ALDH+ cancer stem-like cells.
    Cancer Res. 2017 Oct 26. pii: canres.0366.2017.
    PubMed     Text format     Abstract available
    
    
    
23. LI Y, Zhong C, Liu D, Yu W, et al
    Evidence for Kaposi's Sarcoma originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
    Cancer Res. 2017 Oct 24. pii: canres.1961.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
24. ISHIHARA S, Inman DR, Li WJ, Ponik SM, et al
    Mechano-signal transduction in mesenchymal stem cells induces prosaposin secretion to drive the proliferation of breast cancer cells.
    Cancer Res. 2017 Sep 28. pii: canres.0569.2017.
    PubMed     Text format     Abstract available
    
    
    
25. DE GRANDIS M, Bardin F, Fauriat C, Zemmour C, et al
    JAM-C identifies Src family kinase-activated leukemia-initiating cells and predicts poor prognosis in acute myeloid leukemia.
    Cancer Res. 2017 Sep 28. pii: canres.1223.2017.
    PubMed     Text format     Abstract available
    
    
    
26. KIDDER BL, He R, Wangsa D, Padilla-Nash HM, et al
    SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation.
    Cancer Res. 2017 Sep 26. pii: canres.0828.2017.
    PubMed     Text format     Abstract available
    
    
    
27. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available
    
    
    
28. YANG A, Qin S, Schulte BA, Ethier SP, et al
    MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer.
    Cancer Res. 2017 Sep 26. pii: canres.3452.2016.
    PubMed     Text format     Abstract available
    
    
    
29. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available
    
    
    
30. YANG R, Chen LH, Hansen LJ, Carpenter AB, et al
    Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation.
    Cancer Res. 2017 Sep 22. pii: canres.1018.2017.
    PubMed     Text format     Abstract available
    
    
    
31. SHUKLA V, Rao M, Zhang H, Beers J, et al
    ASXL3 is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.
    Cancer Res. 2017 Sep 21. pii: canres.0570.2017.
    PubMed     Text format     Abstract available
    
    
    
32. DASHZEVEG NK, Taftaf R, Ramos EK, Torre-Healy L, et al
    New Advances and Challenges of Targeting Cancer Stem Cells.
    Cancer Res. 2017 Sep 19. doi: 10.1158/0008-5472.CAN-17-0054.
    PubMed     Text format     Abstract available
    
    
    
33. SONG KH, Choi CH, Lee HJ, Oh SJ, et al
    HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    Cancer Res. 2017;77:5039-5053.
    PubMed     Text format     Abstract available
    
    
    
34. BORRIELLO L, Nakata R, Sheard MA, Fernandez GE, et al
    Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
    Cancer Res. 2017;77:5142-5157.
    PubMed     Text format     Abstract available
    
    
    
35. BHAGAT TD, Chen S, Bartenstein M, Barlowe AT, et al
    Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/beta-Catenin Activation.
    Cancer Res. 2017;77:4846-4857.
    PubMed     Text format     Abstract available
    
    
    
36. METZGER E, Stepputtis SS, Strietz J, Preca BT, et al
    KDM4 inhibition targets breast cancer stem-like cells.
    Cancer Res. 2017 Sep 7. pii: canres.1754.2017.
    PubMed     Text format     Abstract available
    
    
    August 2017
37. YANG F, Wei J, Zhang S, Zhang X, et al
    Shrimp miR-S8 suppresses the stemness of human melanoma stem-like cells by targeting the transcription factor YB-1.
    Cancer Res. 2017 Aug 30. pii: canres.1375.2017.
    PubMed     Text format     Abstract available
    
    
    
38. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    PubMed     Text format     Abstract available
    
    
    
39. DODD RD, Lee CL, Overton T, Huang W, et al
    NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response.
    Cancer Res. 2017;77:4486-4497.
    PubMed     Text format     Abstract available
    
    
    
40. ROHIRA AD, Yan F, Wang L, Wang J, et al
    Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
    Cancer Res. 2017;77:4293-4304.
    PubMed     Text format     Abstract available
    
    
    July 2017
41. REGGIANI F, Labanca V, Mancuso P, Rabascio C, et al
    Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression.
    Cancer Res. 2017 Jul 28. pii: canres.0914.2017.
    PubMed     Text format     Abstract available
    
    
    
42. WANG X, Huang Z, Wu Q, Prager BC, et al
    MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells.
    Cancer Res. 2017 Jul 20. pii: canres.0114.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
43. HOU PC, Li YH, Lin SC, Lin SC, et al
    Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness.
    Cancer Res. 2017 Jun 26. pii: canres.2990.2016.
    PubMed     Text format     Abstract available
    
    
    
44. RODRIGUEZ-HERNANDEZ G, Hauer J, Martin-Lorenzo A, Schafer D, et al
    Infection exposure promotes ETV6-RUNX1 precursor B cell leukemia via impaired H3K4 demethylases.
    Cancer Res. 2017 Jun 19. pii: canres.0701.2017.
    PubMed     Text format     Abstract available
    
    
    May 2017
45. YAN H, Romero-Lopez M, Benitez LI, Di K, et al
    3D mathematical modeling of glioblastoma suggests that transdifferentiated vascular endothelial cells mediate resistance to current standard-of-care therapy.
    Cancer Res. 2017 May 23. pii: canres.3094.2016.
    PubMed     Text format     Abstract available
    
    
    
46. TECH K, Tikunov AP, Farooq H, Morrissy AS, et al
    Pyruvate kinase inhibits proliferation during postnatal cerebellar neurogenesis and suppresses medulloblastoma formation.
    Cancer Res. 2017 May 17. pii: canres.3304.2016.
    PubMed     Text format     Abstract available
    
    
    
47. RODRIGUEZ-BRENES IA, Kurtova AV, Lin C, Lee YC, et al
    Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy.
    Cancer Res. 2017;77:2231-2241.
    PubMed     Text format     Abstract available
    
    
    April 2017
48. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available
    
    
    
49. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available
    
    
    
50. SARKAR S, Mirzaei R, Zemp FJ, Wu W, et al
    Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells.
    Cancer Res. 2017 Apr 17. pii: canres.2171.2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: